ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228115.1	Nilotinib	Bladder urothelial carcinoma	0.010526449	Resistant
ENSG00000228115.1	Nilotinib	Stomach adenocarcinoma	0.021350575	Sensitive